Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125464211 | 12546421 | 1 | I | 20151005 | 20160629 | 20160711 | 20160711 | EXP | CH-SM-2016-05157 | CH-ELI_LILLY_AND_COMPANY-CH201607002169 | ELI LILLY AND CO | 66.35 | YR | F | Y | 67.30000 | KG | 20160711 | CN | CH | CH |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125464211 | 12546421 | 1 | PS | ALIMTA | PEMETREXED DISODIUM | 1 | Unknown | UNK, CYCLICAL | U | U | 21462 | INJECTION | |||||||
| 125464211 | 12546421 | 2 | SS | ALIMTA | PEMETREXED DISODIUM | 1 | Unknown | 500 MG/M2, CYCLICAL | U | U | 21462 | 500 | MG/M**2 | INJECTION | |||||
| 125464211 | 12546421 | 3 | C | CARBOPLATIN. | CARBOPLATIN | 1 | Unknown | UNK, CYCLICAL | U | U | 0 | ||||||||
| 125464211 | 12546421 | 4 | C | ACIDUM FOLICUM STREULI | 2 | Oral | 5 MG, WEEKLY (1/W) | 0 | 5 | MG | /wk | ||||||||
| 125464211 | 12546421 | 5 | C | PANTOZOL | PANTOPRAZOLE SODIUM | 1 | Oral | 40 MG, QD | 0 | 40 | MG | QD | |||||||
| 125464211 | 12546421 | 6 | C | METFORMIN-MEPHA | 2 | Oral | 500 MG, BID | 0 | 500 | MG | BID | ||||||||
| 125464211 | 12546421 | 7 | C | LASIX | FUROSEMIDE | 1 | Oral | 20 MG, QD | 0 | 20 | MG | QD | |||||||
| 125464211 | 12546421 | 8 | C | ATENOLOL MEPHA | 2 | Oral | 100 MG, QD | 0 | 100 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125464211 | 12546421 | 1 | Lung adenocarcinoma |
| 125464211 | 12546421 | 3 | Lung adenocarcinoma |
| 125464211 | 12546421 | 4 | Product used for unknown indication |
| 125464211 | 12546421 | 5 | Product used for unknown indication |
| 125464211 | 12546421 | 6 | Product used for unknown indication |
| 125464211 | 12546421 | 7 | Product used for unknown indication |
| 125464211 | 12546421 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125464211 | 12546421 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125464211 | 12546421 | Erysipelas | |
| 125464211 | 12546421 | Off label use |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125464211 | 12546421 | 1 | 20151005 | 20151207 | 0 | |
| 125464211 | 12546421 | 2 | 20151228 | 0 |